About the Company:
Most expensive share in the Indian equity market, which started as a rubber balloon factory with a funding of Rs.14, 000 way back in the ’40s is now a multibillion legacy that produces quality tyres used all around India & internationally along with a presence in paints & coats, toys, motorsports, and cricket training.
QoQ & YoY Performance:
India’s major pharmaceutical company has declared the results for the third quarter of the fiscal year ending March 2020.
- Net Revenue: Net sales figures remained marginally lower by 0.47% to Rs 4075.75 crores during the period ended December 31, 2019, compared to Rs 4095.03 crores during the period ended December 31, 2018. It rose marginally by 1.70% in comparison to the quarter ending in September 2019.
- EBITDA Margins: The company’s EBITDA margins also increased in Q3FY20 where it stands at 17.08% against the same year before 17.02%.
- Net Profit After Tax: The company’s Net profit during the quarter rose by 5.40% stood at Rs 241.32 crores in December 2019 as against Rs 228.96 crores in September 2019. While it fell down by 17.02% on YOY as it posted 290.83 crores posted in the same quarter last year.
- PAT Margins: PAT Margins reported lower in Q3FY20 at 5.82% against 7.10% in the same quarter last year.
As per Lokesh Sethia, SEBI Registered Research Analyst, the stock is trading at Rs. 73,190.00 per share. MRF company posted a disappointing business result for Q3FY20 due to overall economic weakness and overall auto sector slowdown. Though stock seems good pick at this price. Hence, we recommend it to “BUY” for the target of 77,200 levels for the long term.
This is for the sole purpose to provide client(s) information of EQUITY GLOBAL RESEARCH (EG) and not to interpret as an investment advice. It is also not to consider as an offer or solicitation for the purchase and sale of any financial instrument. Any action taken based on given information contained herein, is your responsibility alone. EQUITY GLOBAL RESEARCH and its subsidiaries/employees/associates will not be liable in any manner for the consequences of such action taken by you. The due diligence we have exercised after checking the correctness and authenticity of the information contained in this recommendation. In case of any inadvertent error in the used information to make this recommendation or action taken based on information the EQUITY GLOBAL RESEARCH or any of its subsidiary or associate or employee shall not be liable in any way responsible for any loss or damage. The recommendations provided here based on either Technical Analysis, Fundamental Analysis or both. EQUITY GLOBAL RESEARCH has issued this document on information obtained from sources it believes to be reliable but not independently verified; Also, the EQUITY GLOBAL RESEARCH makes no promises, guarantee, or accepts no responsibility as to its accuracy or completeness. The opinions contained within the report based on publicly available information at the time of publication and subject to change without any intimation. Any piece of information and disclosure provided herein is in summary form and has been prepared for informational purposes. The recommendations are only valid for the day of the issued report however, trading trends, volumes might vary substantially on a daily basis, and recommendations may change accordingly. The information provided herein is entirely confidential. Any misuse, distribution, modification, copying, or forwarding by any person strictly prohibited. The information provided herein does not constitute a solicitation or offer to buy or sell any security or another financial instrument. The current performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investment will achieve any targeted rates of return, and there is no guarantee against the loss of your entire investment.